Monogram Orthopaedics Net Worth
Monogram Orthopaedics Net Worth Breakdown | MGRM |
Monogram Orthopaedics Net Worth Analysis
Monogram Orthopaedics' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Monogram Orthopaedics' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Monogram Orthopaedics' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Monogram Orthopaedics' net worth analysis. One common approach is to calculate Monogram Orthopaedics' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Monogram Orthopaedics' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Monogram Orthopaedics' net worth. This approach calculates the present value of Monogram Orthopaedics' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Monogram Orthopaedics' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Monogram Orthopaedics' net worth. This involves comparing Monogram Orthopaedics' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Monogram Orthopaedics' net worth relative to its peers.
Enterprise Value |
|
To determine if Monogram Orthopaedics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Monogram Orthopaedics' net worth research are outlined below:
| Monogram Orthopaedics generated a negative expected return over the last 90 days | |
| Monogram Orthopaedics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 365 K. Net Loss for the year was (13.75 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Monogram Orthopaedics generates negative cash flow from operations | |
| About 34.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Knape Noel of 288461 shares of Monogram Orthopaedics at 2.08 subject to Rule 16b-3 |
Monogram Orthopaedics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Monogram Orthopaedics Common. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Monogram Orthopaedics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Follow Monogram Orthopaedics' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 69.31 M.Market Cap |
|
Project Monogram Orthopaedics' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.86) | (0.90) | |
| Return On Capital Employed | (1.25) | (1.19) | |
| Return On Assets | (0.83) | (0.87) | |
| Return On Equity | (1.03) | (0.97) |
When accessing Monogram Orthopaedics' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Monogram Orthopaedics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Monogram Orthopaedics' profitability and make more informed investment decisions.
Evaluate Monogram Orthopaedics' management efficiency
Monogram Orthopaedics has return on total asset (ROA) of (0.6092) % which means that it has lost $0.6092 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2156) %, meaning that it created substantial loss on money invested by shareholders. Monogram Orthopaedics' management efficiency ratios could be used to measure how well Monogram Orthopaedics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 2nd of December 2024, Return On Tangible Assets is likely to drop to -0.9. In addition to that, Return On Capital Employed is likely to grow to -1.19. At this time, Monogram Orthopaedics' Total Assets are very stable compared to the past year. As of the 2nd of December 2024, Total Current Assets is likely to grow to about 15.3 M, while Net Tangible Assets are likely to drop about 2.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.60 | 0.63 | |
| Tangible Book Value Per Share | 0.57 | 0.60 | |
| Enterprise Value Over EBITDA | (3.80) | (3.99) | |
| Price Book Value Ratio | 5.75 | 6.04 | |
| Enterprise Value Multiple | (3.80) | (3.99) | |
| Price Fair Value | 5.75 | 6.04 | |
| Enterprise Value | 64 M | 60.8 M |
The strategic initiatives led by Monogram Orthopaedics' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 145.6083 | Revenue 365 K | Revenue Per Share 0.012 | Return On Equity (1.22) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Monogram Orthopaedics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Monogram Orthopaedics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Monogram Orthopaedics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Knape Noel six days ago Acquisition by Knape Noel of 288461 shares of Monogram Orthopaedics at 2.08 subject to Rule 16b-3 | ||
Merriweather Alfred G over a month ago Acquisition by Merriweather Alfred G of 100000 shares of Monogram Orthopaedics at 1.88 subject to Rule 16b-3 | ||
Mendlein John over two months ago Acquisition by Mendlein John of 20000 shares of Monogram Orthopaedics at 1.88 subject to Rule 16b-3 | ||
Knape Noel over six months ago Acquisition by Knape Noel of 25000 shares of Monogram Orthopaedics at 2.33 subject to Rule 16b-3 | ||
Goddard Noel over a year ago Monogram Orthopaedics exotic insider transaction detected |
Monogram Orthopaedics Corporate Filings
F4 | 26th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 14th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 8th of November 2024 Other Reports | ViewVerify | |
| 30th of October 2024 Other Reports | ViewVerify |
Monogram Orthopaedics Earnings per Share Projection vs Actual
Monogram Orthopaedics Corporate Executives
Elected by the shareholders, the Monogram Orthopaedics' board of directors comprises two types of representatives: Monogram Orthopaedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Monogram. The board's role is to monitor Monogram Orthopaedics' management team and ensure that shareholders' interests are well served. Monogram Orthopaedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Monogram Orthopaedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Douglas Unis | Chief Founder | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.012 | Return On Assets (0.61) | Return On Equity (1.22) |
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.